A new spin on an old model: In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat

Arthritis and Rheumatism

Volumn 42, Issue 10, 1999, Pages 2060-2073

  Jacobson, Peer B ^a   Morgan, Sheryl J ^a   Wilcox, Denise M ^a   Nguyen, Phong ^a   Ratajczak, Christine A ^a   Carlson, Richard P ^a   Harris, Richard R ^a   Nuss, Merrill ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COLLAGEN;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSIS; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; HISTOPATHOLOGY; INFLAMMATION; JOINT CAPSULE; MALE; MYCOBACTERIUM BUTYRICUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PERIOSTITIS; PRIORITY JOURNAL; RAT; SYNOVITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RATS; RATS, INBRED LEW;

EID: 0033509827     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199910)42:10<2060::AID-ANR6>3.0.CO;2-L     Document Type: Article

References (44)

1. Stoerk HC, Bielinski TC, Budzilovich T. Chronic polyarthritis in rats injected with spleen in adjuvants. Am J Pathol 1954;30:616-21.
2. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956;91:95-101.
3. Billingham MEJ. Adjuvant arthritis: the first model. In: Henderson B, Edwards JCW, Pettipher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 389-409.
4. Carlson R, and Jacobson P. Comparison of adjuvant and streptococcal cell wall-induced arthritis in the rat. In: Marshall L, Morgan D, editors. In vivo models of inflammation. Basel: Birkhauser; 1999. p. 1-50.
5. Billingham MEJ. Models of arthritis and the search for antiarthritic drugs. Pharmacol Ther 1983;21:389-428.
6. Lewis AJ, Carlson RP, Chang JY. Experimental models of inflammation. In: Bonta IL, Bray MA, Parnham MJ, editors. Handbook of inflammation. Vol. 5. Amsterdam: Elsevier; 1985. p. 371-97.
7. Van Arman CG. Pathway to adjuvant arthritis. Fed Proc 1976;35: 2442-6.
8. Ward JR, Jones RS. Studies on adjuvant-induced polyarthritis in rats. I. Adjuvant composition, route of injection, and removal of depot site. Arthritis Rheum 1962;5:557-64.
9. Østergaard M, Stoltenberg M, Løvgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I. Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 1997; 40:1856-67.
10. Ward PA. Neutrophils and adjuvant arthritis. Clin Exp Immunol 1997;107:225-6.
11. Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Agents Actions 1988;25:94-105.
12. Winter CA, Nuss GW. Treatment of adjuvant arthritis in rats with anti-inflammatory drugs. Arthritis Rheum 1966;9:394-404.
13. Waltz DT, Dolan MM, DiMartino MJ, Yankell SL. Effects of topical hydrocortisone and acetylsalicyclic acid on the primary lesion of adjuvant-induced arthritis (35811). Proc Soc Exp Biol Med 1971;137:1466-9.
14. Glenn EM. Adjuvant-induced arthritis: effects of certain drugs on incidence, chemical severity and biochemical changes. Am J Vet Res 1966;27:339-52.
15. Waltz DT, DiMartino MJ, Misher A. Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters. J Pharmacol Exp Ther 1971;178:223-31.
16. Stanescu R, Lider O, van Eden W, Holoshitz J, Cohen IR. Histopathology of arthritis induced in rats by active immunization to mycobacterial antigens or by systemic transfer of T lymphocyte lines: a light and electron microscopic study of the articular surface using cationized ferritin. Arthritis Rheum 1987;30:779-92.
17. Jones RS, Ward JR. Studies on adjuvant-induced polyarthritis in rats. II. Histogenesis of joint and visceral lesions. Arthritis Rheum 1963;6:23-35.
18. Sano H, Hla T, Maier JAM, Crofford LJ, Case JP, Maciag T, et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis in rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108.
19. Halloran MM, Szekanecz Z, Barquin N, Haines GK, Koch AE. Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum 1996;39:810-9.
20. Erikson EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation to bone histomorphometry. J Bone Miner Res 1993;8:127-32.
21. Jaffee BD, Kerr JS, Jones EA, Giannaras JV, McGowan M, Ackerman NR. The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats. Agents Actions 1989;27: 344-6.
22. Jacobson PB, Wilcox DM, Morgan SJ, Carlson RP, Harris RR, Nuss ME. Antiarthritic activities of orally administered FK-506, rapamycin, and combinational therapy in rat established adjuvant arthritis [abstract]. Arthritis Rheum 1996;39 Suppl 9:S246.
23. Wilcox DM, Nuss ME, Morgan SJ, Harris RR, Carlson RP, Bell RL, et al. Therapeutic evaluation of selective cyclooxygenase-2 inhibitors in rat established adjuvant arthritis by magnetic resonance imaging and inflammatory parameters [abstract]. Arthritis Rheum 1996;39 Suppl 9:S285.
24. Ward JR, Cloud RS. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats. J Pharmacol Exp Ther 1966;152:116-21.
25. Carlson RP, Baeder WL, Caccese RG, Warner LM, Sehgal SN. Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases. Ann NY Acad Sci 1993;685:86-113.
26. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 1997; 40:1347-65.
27. Beckmann N, Bruttel K, Schuurman H, Mir A. Effects of Sand-immune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology. J Magn Reson 1998;131:8-16.
28. Carlson RP, Datko LJ, O'Neill-Davis L, Blazek EM, DeLustro F, Beideman R, et al. Comparison of inflammatory changes in established type II collagen and adjuvant-induced arthritis using outbred Wistar rats. Int J Immunopharmacol 1985;7:811-26.
29. Blackham A, Burns JW, Farmer JB, Radziwonik H, Westwick J. An x-ray analysis of adjuvant arthritis in the rat: the effect of prednisolone and indomethacin. Agents Actions 1977;7:145-51.
30. Bradbeer JM, Kapadia RD, Sarkar SK, Zhao H, Stroup GB, Swift BA, et al. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis: multiparameter analysis of disease including magnetic resonance imaging and bone mineral density measurements. Arthritis Rheum 1996;39:504-14.
31. Carpenter TA, Everett JR, Hall LD, Harper GP, Hodgson RJ, James MF, et al. High resolution magnetic resonance imaging of arthritic pathology in the rat knee. Skeletal Radiol 1994;23:429-37.
32. Carpenter TA, Everett JR, Hall LD, Harper GP, Hodgson RJ, James MF. Visualisation of subchondral erosion in rat monoarticular arthritis by magnetic resonance imaging. Skeletal Radiol 1995;24:341-9.
33. Borah B, Szeverenyi NM. Quantification of fluid changes in rat leg joints with adjuvant arthritis by a one-dimensional magnetic resonance imaging experiment. Magn Reson Med 1990;15:246-59.
34. Beckmann N, Bruttel K, Mir A, Rudin M. Noninvasive 3D MR microscopy as a tool in pharmacological research: application to a model of rheumatoid arthritis. Magn Reson Imaging 1995;13: 1013-7.
35. Kapadia RD, High WB, Soulleveld HA, Bertolini D, Sarkar SK. Magnetic resonance microscopy in rat skeletal research. Magn Reson Microsc 1993;30:247-50.
36. Delnomdedieu M, Hedlund LW, Johnson GA, Maronpot RR. Magnetic resonance microscopy: a new tool for the toxicologic pathologist. Toxicol Pathol 1996;24:36-44.
37. Terrier F, Hricak H, Revel D, Alpers CE, Reinhold CE, Levine J, et al. Magnetic resonance imaging and spectroscopy of the periarticular inflammatory soft-tissue changes in experimental arthritis of the rat. Invest Radiol 1985;20:813-23.
38. Borah B, Francis MD, Hovancik K, Boyce JT, Szeverenyi NM. A quantitative one-dimensional magnetic resonance imaging technique in adjuvant arthritis: the assessment of disease progression and indomethacin efficacy. J Rheumatol 1995;22:855-62.
39. Robins SP, Duncan A. Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur. Biochim Biophys Acta 1987;914:233-9.
40. Rivera M, Vaquero JJ, Santos A, Ruiz-Cabello J, del Pozo F. MRI visualization of small structures using improved surface coils. Magn Reson Imaging 1998;16:157-66.
41. Pearson CM, Wood FD. Studies of arthritis and other lesions induced by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am J Pathol 1963;42: 73-95.
42. Pearson CM, Wood FD. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440-59.
43. Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol 1960;85:403-17.
44. Gaffney K, Cookson J, Blake D, Coumbe A, Blades S. Quantification of rheumatoid synovitis by magnetic resonance imaging. Arthritis Rheum 1995;38:1610-7.